Healthcare Additive Manufacturing Market Size, Share, Growth, and Industry Analysis, By Type (Metals and Alloys,Polymers,Biological Cells,Others), By Application (Medical Implants,Prosthetics,Wearable Devices,Tissue Engineering,Others), Regional Insights and Forecast to 2035

Healthcare Additive Manufacturing Market Overview

The global Healthcare Additive Manufacturing Market size is projected to grow from USD 248.34 million in 2026 to USD 263 million in 2027, reaching USD 413.65 million by 2035, expanding at a CAGR of 5.9% during the forecast period.

Healthcare additive manufacturing (AM), also known as 3D printing in medical applications, enables layer-by-layer fabrication of custom implants, surgical guides, prosthetics, and bioprinted scaffolds via CAD-to-part workflows. In 2024, polymer and metal AM accounted for over 60 % share of materials used in medical 3D printing. The medical implant application segment contributed over 32 % share of healthcare AM device production, followed by prosthetics and surgical instruments.

In the United States, healthcare additive manufacturing is in advanced adoption, with over 50 hospital-based AM labs installed by 2024. The U.S. dental 3D printing market alone generated over USD 1.2 billion in output in 2024. The U.S. medical device AM segment represented over 86 % share of North American healthcare 3D printing volume. Many specialty clinics have integrated point-of-care printing in orthopedics, maxillofacial surgery, and custom prosthetics fabrication. The U.S. regulatory environment supports additive device innovation, with more than 1,600 devices cleared via 510(k) pathways by 2026, promoting AM uptake among device OEMs and hospitals alike.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 35 % of new orthopedic implant projects now include additive manufacturing customization to meet patient-specific anatomical requirements.
• Major Market Restraint: Only about 10 biocompatible metal and polymer systems are currently qualified for long-term implant use, limiting material diversity.
• Emerging Trends: In 2025, over 20 research consortia globally are funding bioprinting of vascularized tissues and organ scaffolds using healthcare AM.
• Regional Leadership: North America commanded over 36 % of global healthcare AM share in 2024, led by U.S. device manufacturers and hospital adoption.
• Competitive Landscape: The top two AM firms control over 30 % of medical AM market share, while numerous niche players target specialized surgical tool segments.
• Market Segmentation: Polymer-based AM leads with ~ 55 % share in healthcare AM materials, followed by metals/alloys (~ 30 %) and biological cell printing (~ 10 %).
• Recent Development: In 2024, several manufacturers released hybrid AM devices combining metal and polymer printheads for multi-material medical parts.

Healthcare Additive Manufacturing Market Latest Trends

Healthcare additive manufacturing is embracing hybrid printing systems that combine polymers, metals, and bioinks in a single platform. In 2024, more than 25 % of new AM systems shipped had dual-metal/polymer capabilities. Tissue engineering breakthroughs are also emerging: over 15 clinical trials worldwide are testing bioprinted cartilage, bone, or skin scaffolds created via AM. The trend toward point-of-care clinic-based printing is gaining traction, with more than 50 hospitals in the U.S. alone operating in-house 3D printing labs. Custom surgical guides, used in over 40 % of complex surgeries by 2025, are now printed onsite within hours.

Healthcare Additive Manufacturing Market Dynamics

The Healthcare Additive Manufacturing Market is primarily driven by the growing demand for personalized implants, surgical models, and patient-specific prosthetics that enable precise treatment outcomes and reduced recovery times. In 2024, the medical implant segment accounted for over 32% of the total healthcare additive manufacturing revenue, reflecting strong adoption of 3D-printed orthopedic, dental, and cranial devices. Continuous advancements in biocompatible materials, multi-material printing systems, and imaging integration technologies have significantly expanded the applications of additive manufacturing across hospitals, research institutes, and medical device manufacturers.

DRIVER

"The key driver is the rising demand for personalized medical devices tailored to individual patients’ anatomical geometries. "

With an aging global population, over 20 % of adults above 50 require orthopedic or dental interventions, fueling adoption of patient-specific implants. Increasing prevalence of chronic conditions and trauma further drives demand. Bioprinting and regenerative medicine innovations constitute another major driver: more than 20 global projects are conducting trials using bioprinted tissues and organ scaffolds. Hospitals are investing in in-house AM labs, and over 50 U.S. medical centers now operate point-of-care printing facilities. Reduced waste, faster prototyping, and supply chain localization also encourage device OEMs to use additive manufacturing in early development and small-series production. Moreover, improved scanning/medical imaging to CAD workflows compress design-to-fabrication time to hours, facilitating surgical planning and immediate customization.

RESTRAINT

"High regulatory burden and lengthy validation processes remain a major restraint."

Only a handful of additive manufacturing systems and materials currently hold full certification for medical implant use. Material qualification is limited: fewer than 10 metal alloys and certified polymers are cleared under regulated environments. Equipment costs remain prohibitive — an industrial metal AM system can cost over USD 500,000, restricting use to major hospitals and large OEMs. Expertise is another constraint: clinical and engineering staff must be trained in both medical device and additive technologies. There is also a limited pipeline of clinical data: few longitudinal studies exist on the longevity and biocompatibility of AM implants. Intellectual property and standardization gaps further impede adoption, as overlapping patent claims and lack of unified protocols hamper scaling.

OPPORTUNITY

"Healthcare AM unlocks opportunities in hybrid implants combining metal cores and polymer overlays, bioprinted scaffolds, and cell-laden constructs. "

Modular AM platforms enabling switching among metal, polymer, and bioinks present new growth paths. As emerging economies expand medical infrastructure, localized AM fabrication centers become feasible, reducing import reliance. The push toward decentralized manufacturing and telemedicine amplifies opportunities — remote clinics could print implants regionally. Development of resorbable and biodegradable AM materials for temporary implants opens new markets. Partnerships among hospitals, device makers, and software firms to co-develop AM workflows are increasingly common. Also, regulatory agencies are becoming more receptive: over 1,600 devices have been cleared thus far using AM methods, signaling pathway maturation.

CHALLENGE

"Ensuring reproducibility and quality control is a major challenge"

Uneven layer deposition or small deviations can lead to defects, with defect rates in worst cases exceeding 10 %. Bioprinting challenges include maintaining cell viability, vascularization, and sterility across lengthy print times. Scaling from prototyping to manufacturing volumes while maintaining cost efficiency is difficult due to limited machine throughput. The fragmented regulatory landscape across regions adds complexity in global rollouts. Licensing and IP conflicts are frequent: more than 25 % of additive manufacturing patents overlap with medical device patents, complicating freedom-to-operate. Also, integrating AM parts with traditional manufacturing and supply chains requires hybrid workflows, raising process complexity and validation burdens.

Healthcare Additive Manufacturing Market Segmentation

The Healthcare Additive Manufacturing Market segments by Type and Application. By Type, segments include Metals and Alloys, Polymers, Biological Cells, and Others (ceramics, composites). By Application, segmentation includes Medical Implants, Prosthetics, Wearable Devices, Tissue Engineering, and Others (surgical tools, anatomical models). This segmentation enables device manufacturers, hospitals, and service bureaus to align strategies with material-application combinations, assessing Healthcare Additive Manufacturing Market Size, Market Share, and growth potential.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

• Metals and Alloys: Metal AM is essential for load-bearing implants in orthopedics, spinal, cranial, and dental fields. Titanium alloys like Ti-6Al-4V remain dominant, representing more than 70 % of metal medical implant fabrication. More than 40 % of high-end AM systems shipped in 2024 were for metal printing. The strength, fatigue resistance, and biocompatibility of metal AM parts justify adoption for critical anatomical implants. Techniques like DMLS, EBM, and LPBF are standard. Metal AM penetration in medical device OEM portfolios is expanding, particularly in high-value orthopedic and spine applications.
• Polymers: Polymers form the largest share in healthcare AM materials—accounting for ~ 55 % of medical AM volume. Medical-grade resins, biocompatible photopolymers, PEEK, PEAK, and ULTEM are used in surgical guides, dental devices, and prosthesis shells. Polymer AM enables faster iteration, lower cost, and complex geometries such as lattice structures. More than 30 polymeric resins obtained regulatory clearance by 2024. Polymer printing technologies like SLA, DLP, and MJ systems are widespread in dental, ENT, and craniofacial devices.
• Biological Cells: Bioprinting or cell-based printing is an emerging type, representing around 10 % of advanced healthcare AM research activity. These systems deposit living cells in scaffolds or hydrogels to form tissues like cartilage, skin, and vascular conduits. Early stage clinical trials include bioprinted cartilage and bone scaffolds. Over 12 research programs worldwide are targeting vascularized tissue constructs by 2026. Bioprinting combines cell biology, material science, and printing control to push regenerative medicine.
• Others (Ceramics, Composites, Hybrid Materials): This category includes ceramic inks for bone repair, composite polymer-ceramic blends, and hybrid materials combining polymers and metals. Ceramic AM is used in dental restoration and bone graft substitutes, representing a small but growing share (< 5 %) of medical AM production. Composite materials combining carbon fiber and polymer allow strength-to-weight tuning in prosthetics and orthotics. Hybrid printing systems that deposit ceramics or composites alongside polymers are increasingly adopted in advanced medical device prototyping.

BY APPLICATION

• Medical Implants: Implants account for over 32 % of healthcare AM applications, including orthopedic, spinal, dental, cranial, and hip implants. Custom geometries, porous structures for osseointegration, and patient-specific anatomical matching make additive manufacturing ideal. More than 5,000 patient-specific implants have been clinically applied using AM technologies since 2020. Metal AM systems dedicate ~ 60 % of their workload to medical implant fabrication.
• Prosthetics: Prosthetics (limb, joint, custom socket components) represent ~ 20 % of medical AM usage. Low-cost, lightweight structures, lattice interior, and integrated comfort fittings are enabled by AM. Tens of thousands of prosthetic sockets have been 3D-printed globally. AM reduces production time from weeks to days for custom prosthetic fittings.
• Wearable Devices: Wearables such as sensor housings, hearing aid shells, and patches comprise ~ 15 % of AM applications. Custom-shaped shells printed to fit anatomy are common in hearing aids—over 1 million hearing aid parts are processed via AM annually. Flexible polymer printing is used for conformal sensors and biosignal recording devices.
• Tissue Engineering: Tissue engineering through AM (bioprinting scaffolds, cartilage, bone, vascularization) is a high-potential but nascent segment, currently responsible for ~ 8 % of advanced R&D deployments. Over 12 in vivo bioprinting trials are underway globally. Scaffold designs involve hierarchical pore gradients and multiple cell types.
• Others (Surgical Tools, Anatomical Models, Guides): This includes surgical cutting guides, anatomical models for planning, custom instruments, and test jigs—comprising ~ 15 % of AM volume. Hospitals print thousands of anatomical models per year for preoperative planning. Over 40 % of complex surgeries now use printed guides.

Regional Outlook for the Healthcare Additive Manufacturing Market

The Healthcare Additive Manufacturing Market exhibits a dynamic global presence, with major contributions from North America, Europe, Asia-Pacific, and the Middle East & Africa, collectively accounting for over 95% of total global deployment of healthcare-focused additive manufacturing systems. As of 2025, approximately 2,800 certified medical 3D printing facilities are operating worldwide, supporting applications across implants, surgical tools, and bioprinted tissues. North America leads with nearly 38% of global installations, followed by Europe at 28%, Asia-Pacific at 25%, and the Middle East & Africa with approximately 9%.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates healthcare additive manufacturing, contributing over 36 % of global volume in 2024. The United States leads, with American hospitals employing over 50 in-house AM labs and U.S. dental AM revenues exceeding USD 1.2 billion. U.S. device OEMs integrate AM for orthopedic, dental, and craniofacial implants with over 1,600 devices cleared for clinical use. Canada supports medical AM adoption through research partnerships and hospital systems. Mexico is growing prosthetic printing and surgical tool fabrication. Costa Rica and Puerto Rico serve niche surgical modeling and medical component support. The region benefits from strong regulatory pathways and favorable reimbursement schemes, fueling sustained growth.

The North America Healthcare Additive Manufacturing Market accounts for approximately 38% of the global market share in 2025, estimated at USD 89.1 million, and is projected to reach around USD 148.3 million by 2034, registering a 5.7% CAGR over the forecast period. The region remains the global leader in healthcare additive manufacturing, driven by advanced research infrastructure, a strong industrial base, and continuous innovation in 3D-printed medical technologies. The United States and Canada collectively contribute to over 420 operational additive manufacturing facilities, specializing in biocompatible metals, polymers, and tissue engineering applications. More than 45% of healthcare 3D printing activities in North America are focused on medical implants, prosthetics, and dental restoration solutions, while approximately 30% serve the bioprinting and customized surgical instrument segment.

North America – Major Dominant Countries in the Healthcare Additive Manufacturing Market

• United States: Projected to reach USD 105.4 million by 2034, representing 27% global share and expanding at a 5.8% CAGR, driven by more than 300 research institutions engaged in bioprinting and strong regulatory pathways for 3D-printed medical devices.
• Canada: Expected to achieve USD 18.2 million by 2034, accounting for 5% market share and growing at a 5.6% CAGR, supported by investments in precision medical manufacturing and digital health innovation across Ontario and Quebec.
• Mexico: Forecasted at USD 9.4 million by 2034, capturing 3% share and a 5.5% CAGR, benefiting from cost-effective contract manufacturing operations and expanding prosthetics and dental additive manufacturing facilities.
• Costa Rica: Estimated to reach USD 4.1 million by 2034, holding 1.3% market share with a 5.4% CAGR, supported by growth in export-oriented medical device assembly and additive prototyping partnerships.
• Puerto Rico: Anticipated to achieve USD 3.5 million by 2034, representing 1% share and a 5.3% CAGR, primarily focusing on small-scale biocompatible implant production and collaboration with U.S.-based biomedical firms.

EUROPE

Europe holds about 28 % of global healthcare AM share. The region’s medical device sector emphasizes regulated additive implant production and hospital adoption. Germany leads in orthopedic and spinal implant printing with hospital networks hosting AM pilot centers. The UK, France, Italy, and Netherlands form Europe’s innovation core for custom implant, bioprinting, and surgical guide development. Over 20 European reimbursement programs support patient-specific devices. Many European hospitals maintain 3D printing labs for modeling and surgical planning. Collaboration among medtech firms and academic centers drives advanced AM applications.

The Europe Healthcare Additive Manufacturing Market represents nearly 30% of the global market share in 2025, valued at approximately USD 70.3 million, and is projected to expand steadily at a 5.9% CAGR through 2034, reaching close to USD 117.8 million. Europe’s strong position in the market is underpinned by its advanced medical research ecosystem, well-established regulatory framework, and extensive adoption of additive manufacturing across hospitals, research laboratories, and medical device companies. The region benefits from substantial investments in healthcare innovation programs supported by the European Union’s Horizon funding, which has sponsored more than 350 additive manufacturing and bioprinting projects since 2020.

Europe – Major Dominant Countries in the Healthcare Additive Manufacturing Market

• Germany: Estimated to reach USD 28.4 million by 2034, holding approximately 11% market share with a 6.0% CAGR, driven by the country’s robust industrial base, government-supported biomedical research programs, and the presence of over 150 active additive manufacturing companies specializing in 3D-printed medical implants, prosthetics, and biocompatible materials.
• United Kingdom: Projected at USD 22.9 million by 2034, representing 9% share and a 5.8% CAGR, supported by the National Health Service (NHS) initiatives promoting in-hospital 3D printing labs, as well as collaborations between universities and healthcare startups focused on patient-specific prosthetics and surgical models.
• France: Expected to achieve USD 19.7 million by 2034, capturing 8% market share and expanding at a 5.7% CAGR, with major growth driven by innovations in bioprinting for tissue regeneration, dental restoration, and vascular implant manufacturing across key research hubs in Paris and Lyon.
• Netherlands: Forecasted to reach USD 13.1 million by 2034, representing 5% of the regional market and growing at a 5.9% CAGR, backed by a strong startup ecosystem and high adoption of digital healthcare manufacturing technologies that enable faster prototype development and production scalability.
• Italy: Anticipated to record USD 10.4 million by 2034, accounting for 4% share and a 5.6% CAGR, benefiting from increased adoption of 3D-printed orthopedic devices and dental prosthetics through collaborations between hospitals, universities, and additive technology providers.

ASIA-PACIFIC

Asia-Pacific commands rapid expansion in healthcare additive manufacturing, with China holding over 30 % of the region’s share. China invests heavily in hospital-based AM labs, metal implant printing, and domestic OEM integration. Japan and South Korea contribute advanced biomaterial and hybrid printer technologies. India’s AM startup ecosystem has grown from ~ 10 to over 50 firms between 2020 and 2025, with applications in prosthetics, dental, and orthopedic innovation. ASEAN countries adopt AM in clinical settings. The region’s medical tourism, large patient base, and government funding further accelerate demand and capacity buildup.

The Asia-Pacific Healthcare Additive Manufacturing Market accounts for nearly 22% of the global market share in 2025, valued at approximately USD 51.6 million, and is projected to grow significantly, reaching around USD 90.8 million by 2034, expanding at a 6.4% CAGR. This regional growth is driven by rapid advancements in healthcare infrastructure, accelerating government funding for biomedical research, and expanding manufacturing capabilities across major economies such as China, Japan, South Korea, India, and Australia. Asia-Pacific has witnessed a remarkable increase in the integration of 3D printing in medical device production, particularly in orthopedic implants, dental prosthetics, and tissue-engineered scaffolds, accounting for more than 40% of the region’s total medical manufacturing innovations.

Asia-Pacific – Major Dominant Countries in the Healthcare Additive Manufacturing Market

• China: Estimated to reach USD 28.2 million by 2034, holding around 11% of the global market share and expanding at a 6.6% CAGR, supported by the presence of more than 400 medical 3D printing companies and government initiatives promoting localized production of biocompatible implants, surgical guides, and dental materials.
• Japan: Projected at USD 19.5 million by 2034, accounting for 7% market share and a 6.2% CAGR, driven by advanced R&D in bioprinting technologies, university-led regenerative medicine programs, and integration of 3D printing in hospital networks for orthopedic and cardiovascular applications.
• India: Expected to achieve USD 15.3 million by 2034, representing 6% market share with a 6.5% CAGR, fueled by national healthcare digitization programs, increased private investment in medical device startups, and expansion of cost-effective 3D printing facilities for prosthetics and implants.
• South Korea: Forecasted to reach USD 13.7 million by 2034, contributing 5% share and a 6.3% CAGR, supported by robust innovation funding, government collaboration with research universities, and growing demand for 3D-printed surgical instruments and orthopedic components.
• Australia: Anticipated to record USD 9.8 million by 2034, with 3% share and a 6.1% CAGR, strengthened by strategic healthcare innovation policies, active participation of research organizations in bioprinting development, and increasing clinical trials involving 3D-printed tissue models.

MIDDLE EAST & AFRICA

The Middle East & Africa region is an emerging segment in healthcare additive manufacturing, with growth from smart hospitals, medical tourism, and regional investments. The UAE, Saudi Arabia, and Israel lead initiatives to deploy in-hospital 3D printing. Many GCC hospitals are adding additive labs for anatomical models and implant support. South Africa and Egypt adopt AM for prosthetics and surgical guides. Regional service providers partner with global AM firms to support device supply chains. As regulatory frameworks mature and health infrastructure is upgraded, AM adoption is expected to accelerate across MEA.

The Middle East & Africa Healthcare Additive Manufacturing Market represents approximately 9% of the global market share in 2025, valued at around USD 21.1 million, and is anticipated to reach nearly USD 35.9 million by 2034, growing at a 5.5% CAGR. The region is witnessing strong adoption of healthcare additive manufacturing technologies, particularly across the Gulf Cooperation Council (GCC) nations, where governments are investing heavily in smart healthcare infrastructure and localized 3D printing facilities. The United Arab Emirates and Saudi Arabia jointly account for nearly 45% of regional additive manufacturing output, with more than 120 operational medical 3D printing laboratories focused on dental applications, orthopedic implants, and prosthetics.

Middle East & Africa – Major Dominant Countries in the Healthcare Additive Manufacturing Market

• United Arab Emirates (UAE): Expected to reach USD 10.6 million by 2034, accounting for 3% global share and expanding at a 5.7% CAGR, supported by over 60 operational additive facilities and government-driven healthcare digitization projects.
• Saudi Arabia: Forecasted at USD 8.3 million by 2034, representing 2.5% share with a 5.6% CAGR, driven by national investments exceeding USD 500 million in medical manufacturing infrastructure and bioprinting initiatives.
• South Africa: Estimated at USD 6.7 million by 2034, holding 2% share and 5.4% CAGR, benefiting from additive innovation clusters in Johannesburg and Cape Town focusing on affordable prosthetics and orthopedic solutions.
• Israel: Projected to achieve USD 5.4 million by 2034, capturing 1.5% share with 5.3% CAGR, propelled by university-led bioprinting research and expansion in regenerative medicine material development.
• Qatar: Anticipated at USD 4.9 million by 2034, representing 1% market share with a 5.2% CAGR, leveraging digital healthcare investments and growing research collaborations for customized medical device production.

List of Top Healthcare Additive Manufacturing Companies

• GE Additive
• 3D Systems, Inc.
• EnvisionTEC
• regenHU
• Allevi
• EOS GmbH
• Materialise N.V.
• Stratasys Ltd.
• Nanoscribe GmbH
• GPI Prototype and Manufacturing Services

GE Additive: GE Additive leads the global healthcare additive manufacturing market with advanced metal 3D printing systems used in orthopedic implants and dental applications across over 70 countries.

3D Systems, Inc.: 3D Systems dominates polymer-based healthcare additive manufacturing, providing biocompatible materials and precision medical device printing solutions adopted by more than 1,200 hospitals worldwide.

Investment Analysis and Opportunities

Investment in healthcare additive manufacturing has surged: by 2024, over USD 500 million in venture and strategic funding has targeted bioprinting, medical AM startups, and hybrid printing technologies. From 2021–2024, medical AM investment rounds grew by over 60 %. Roughly 40 % of medtech R&D budgets now allocate funds to additive prototypes and custom part validation. Opportunities lie in localized manufacturing in emerging markets, providing hospital-based fabrication instead of import. The shift toward decentralized, point-of-care printing enables reimbursement models oriented to patient-specific care.

New Product Development

Innovation in the Healthcare Additive Manufacturing Market is advancing rapidly as manufacturers, research institutions, and medical device companies focus on improving precision, biocompatibility, and scalability of 3D-printed medical solutions. As of 2025, more than 1,500 patented healthcare additive manufacturing products have been introduced globally, covering implants, surgical instruments, prosthetics, dental crowns, and tissue scaffolds. The industry has seen a 40% rise in new polymer-based medical product designs between 2023 and 2025, driven by advancements in biocompatible materials such as polyether ether ketone (PEEK), medical-grade nylon, and polylactic acid (PLA).

Five Recent Developments

• In 2024, major AM OEMs launched hybrid metal-polymer systems capable of printing structural implants and flexible overlays in a single build.
• In 2025, a new photopolymer resin gained regulatory clearance for long-term implant use, extending AM into critical load-bearing bone devices.
• In 2023, a hospital network installed more than 20 point-of-care additive labs across its system, producing surgical guides locally.
• In 2024, a consortium published clinical outcomes of over 200 patients implanted with AM spine cages, confirming fusion rates > 90 %.
• In 2025, several device OEMs introduced AI-based lattice optimization tools that integrate directly into AM slicing software, enabling automated strength-weight balance.

Report Coverage of Healthcare Additive Manufacturing Market

This Healthcare Additive Manufacturing Market Report presents in-depth coverage of market dynamics, segmentation, regional insights, competitive landscape, investment analysis, product development, and future outlook. It analyzes Type segments (Metals and Alloys, Polymers, Biological Cells, Others) and Application segments (Medical Implants, Prosthetics, Wearable Devices, Tissue Engineering, Others), quantifying their share and growth potential. Regional breakdown includes North America, Europe, Asia­Pacific, and Middle East & Africa, each with country-level adoption insights. The report profiles the top two companies (GE Additive and 3D Systems, Inc.) with their product portfolios, market share, and technological initiatives. Investment analysis assesses capital flows, strategic partnerships, and opportunities in hospital-based AM and bioprinting.

Healthcare Additive Manufacturing Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 248.34 Million in 2026
Market Size Value By	USD 413.65 Million by 2035
Growth Rate	CAGR of 5.9% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Metals and Alloys Polymers Biological Cells Others By Application : Medical Implants Prosthetics Wearable Devices Tissue Engineering Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample